Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: Invest New Drugs. 2018 Apr 3;36(6):1016–1025. doi: 10.1007/s10637-018-0591-z

Table 5.

Mutation results for patients treated at 75mg daily

Tumor type PTEN
loss
PIK3CA
mutation
AKT
mutation
BRAF
mutation
KRAS
mutation
NRAS
mutation
PR or
SD
Endometrium Yes Yes No Unk Unk Unk SD
Endometrium Yes Yes No Unk Unk Unk
Endometrium Yes Yes Unk No Unk Yes SD
Endometrium Yes No No Unk Unk Unk SD
Endometrium Yes No No Unk Unk Unk SD
Endometrium Yes No No Unk Unk Unk
Endometrium Yes No Unk No No No
Endometrium No Yes No Unk Unk Unk PR
Endometrium Unk Yes Unk No No Unk
Endometrium Unk Yes Unk No Yes No
Prostate Yes No Unk Unk Unk Unk SD
Prostate Yes No Unk Unk Unk Unk SD
Prostate Yes No Unk Unk Unk Unk
Prostate No No Unk Unk Unk Unk SD
Prostate No No Unk Unk Unk Unk
Prostate No No Unk Unk Unk Unk
Prostate Unk No Unk Unk Unk Unk
Prostate Unk No Unk Unk Unk Unk
Ovary Yes No Unk No No Unk PR
Ovary Yes No Unk No No Unk
Ovary No No Unk No No Unk
Ovary No No Unk No No Unk
Ovary v unknown primary Yes No Unk No Yes Unk
Colon/rectum Yes Yes No No No Unk
Colon/rectum Yes No Unk Unk Unk Unk
Colon/rectum Yes No Unk No Unk Unk
Colon/rectum No Yes Unk No No Unk
Cervix Yes No Unk Unk Unk Unk
Cervix Yes No Unk No No No
Head/neck Yes No Unk Unk Unk Unk
Head/neck Unk Yes Unk No No No
Breast No No No Unk Unk Unk
Hepatocellular Yes No Unk Unk Unk Unk
Leiomyosarcoma Yes No Unk Unk Unk Unk

Abbreviation: Unk, unknown; PR, partial response; SD, stable disease >6 months